...
trml-img

Tourmaline Bio Inc., Common Stock

TRML

NSQ

$20.601

+$0.73

(3.67%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$509.52M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
140.95K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$12.12 L
$48.31 H
$20.601

About Tourmaline Bio Inc., Common Stock

Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune and inflammatory diseases. It develops TOUR006, a human anti-IL-6 monoclonal antibody that selectively binds to interleukin-6, a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The company's development pipeline comprises medicines and therapies for the atherosclerotic cardiovascular disease (ASCVD) and thyroid eye disease (TED). The company was formerly known as Tourmaline Bio, LLC and changed its name to Tourmaline Bio, Inc. in September 2022. Tourmaline Bio, Inc. was founded in 2021 and is headquartered in New York, New York. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameTRMLSectorS&P500
1-Week Return-18.5%-3.39%-3.47%
1-Month Return-18.96%-3.25%-0.29%
3-Month Return-5.38%-11.61%4.5%
6-Month Return27.78%-5.89%6.91%
1-Year Return4.58%2.65%23.79%
3-Year Return-86.62%0.56%28.43%
5-Year Return-87.77%34.63%83.64%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue379.00K447.00K623.00K6.00K33.00K[{"date":"2019-12-31","value":60.83,"profit":true},{"date":"2020-12-31","value":71.75,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":0.96,"profit":true},{"date":"2023-12-31","value":5.3,"profit":true}]
Gross Profit(379.00K)(447.00K)(623.00K)(6.00K)(33.00K)[{"date":"2019-12-31","value":-37900000,"profit":false},{"date":"2020-12-31","value":-44700000,"profit":false},{"date":"2021-12-31","value":-62300000,"profit":false},{"date":"2022-12-31","value":-600000,"profit":false},{"date":"2023-12-31","value":-3300000,"profit":false}]
Gross Margin---(Infinity%)(Infinity%)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Operating Expenses18.00M22.24M904.0019.70M45.41M[{"date":"2019-12-31","value":39.64,"profit":true},{"date":"2020-12-31","value":48.97,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":43.39,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(18.38M)(22.68M)(904.00)(19.70M)(45.41M)[{"date":"2019-12-31","value":-1837800000,"profit":false},{"date":"2020-12-31","value":-2268400000,"profit":false},{"date":"2021-12-31","value":-90400,"profit":false},{"date":"2022-12-31","value":-1970100000,"profit":false},{"date":"2023-12-31","value":-4540900000,"profit":false}]
Total Non-Operating Income/Expense-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Pre-Tax Income(18.16M)(22.71M)(904.00)(19.70M)(42.12M)[{"date":"2019-12-31","value":-1815500000,"profit":false},{"date":"2020-12-31","value":-2270700000,"profit":false},{"date":"2021-12-31","value":-90400,"profit":false},{"date":"2022-12-31","value":-1970100000,"profit":false},{"date":"2023-12-31","value":-4212400000,"profit":false}]
Income Taxes--(47.21M)--[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-4721000000,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations---(19.70M)(42.12M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-1970100000,"profit":false},{"date":"2023-12-31","value":-4212400000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(18.16M)(22.71M)(904.00)(19.70M)(42.12M)[{"date":"2019-12-31","value":-1815500000,"profit":false},{"date":"2020-12-31","value":-2270700000,"profit":false},{"date":"2021-12-31","value":-90400,"profit":false},{"date":"2022-12-31","value":-1970100000,"profit":false},{"date":"2023-12-31","value":-4212400000,"profit":false}]
EPS (Diluted)-(0.16)(23.80)(18.70)(6.32)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-16,"profit":false},{"date":"2021-12-31","value":-2380,"profit":false},{"date":"2022-12-31","value":-1870,"profit":false},{"date":"2023-12-31","value":-631.68,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

TRML
Cash Ratio 38.70
Current Ratio 40.33

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

TRML
ROA (LTM) -23.82%
ROE (LTM) -31.82%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

TRML
Debt Ratio Lower is generally better. Negative is bad. 0.02
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.98

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

TRML
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 1.59
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Tourmaline Bio Inc. share price today?

Tourmaline Bio Inc. (TRML) share price today is $20.601

Can Indians buy Tourmaline Bio Inc. shares?

Yes, Indians can buy shares of Tourmaline Bio Inc. (TRML) on Vested. To buy Tourmaline Bio Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TRML stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Tourmaline Bio Inc. be purchased?

Yes, you can purchase fractional shares of Tourmaline Bio Inc. (TRML) via the Vested app. You can start investing in Tourmaline Bio Inc. (TRML) with a minimum investment of $1.

How to invest in Tourmaline Bio Inc. shares from India?

You can invest in shares of Tourmaline Bio Inc. (TRML) via Vested in three simple steps:

  • Click on Sign Up or Invest in TRML stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Tourmaline Bio Inc. shares
What is Tourmaline Bio Inc. 52-week high and low stock price?

The 52-week high price of Tourmaline Bio Inc. (TRML) is $48.31. The 52-week low price of Tourmaline Bio Inc. (TRML) is $12.12.

What is Tourmaline Bio Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Tourmaline Bio Inc. (TRML) is

What is Tourmaline Bio Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Tourmaline Bio Inc. (TRML) is 1.59

What is Tourmaline Bio Inc. dividend yield?

The dividend yield of Tourmaline Bio Inc. (TRML) is 0.00%

What is the Market Cap of Tourmaline Bio Inc.?

The market capitalization of Tourmaline Bio Inc. (TRML) is $509.52M

What is Tourmaline Bio Inc.’s stock symbol?

The stock symbol (or ticker) of Tourmaline Bio Inc. is TRML

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top